# Hypertension in Young Adults Trial

> **NCT05370599** · PHASE2 · TERMINATED · sponsor: **University of California, San Francisco** · enrollment: 36 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Anti-hypertensive agent: amlodipine
- **DRUG:** Anti-hypertensive agent: Chlorthalidone
- **DRUG:** Anti-hypertensive agent: Losartan
- **DEVICE:** Home BP monitoring with cuffed device
- **DEVICE:** Home BP monitoring with cuffed device + BP patch
- **DEVICE:** Home BP monitoring with cuffed device + BP watch

## Key facts

- **NCT ID:** NCT05370599
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-04-15
- **Primary completion:** 2026-01-07
- **Final completion:** 2026-01-07
- **Target enrollment:** 36 (ACTUAL)
- **Why stopped:** Funding limitations.
- **Last updated:** 2026-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05370599

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05370599, "Hypertension in Young Adults Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05370599. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*